2 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 2 |
Follow Hemangioma, Capillary: new trials by email Literature Review of Hemangioma, Capillary trials Research Report on Hemangioma, Capillary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas topical 0.5% Timolol, Control (placebo) group - Hemangioma, Infant | Early Phase 1 | Terminated | Oregon Health and Science University | 6 | 2010-03-01 | 2017-07-05 |
| Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease Avastin - Hemangioblastomas, Von Hippel Lindau Disease | Early Phase 1 | Terminated | Dartmouth-Hitchcock Medical Center | 1 | 2009-12-01 | 2012-05-11 |
Hemangioblastoma (1) · Hemangioma (1) · von Hippel-Lindau Disease (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Vascular Tissue (2) · Abnormalities, Multiple (1) · Angiomatosis (1) · Cardiovascular Diseases (1) · Ciliopathies (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hemangioma (1) · Nervous System Diseases (1) · Neurocutaneous Syndromes (1) · Vascular Diseases (1)
Bevacizumab (1) · Population Groups (1) · Timolol (1)
Dartmouth-Hitchcock Medical Center (1) · Oregon Health and Science University (1)
United States (2)
Alfons L. Krol, M.D. (1) · J Marc Pipas, MD (1)